LATEST

• BUSINESS Pfizer to Drop Avastin, Herceptin Biosimilars in Japan, Halving Portfolio
  October 14, 2026

• BUSINESS Asahi Kasei’s Pritelivir Scores US Approval for HSV Infections
  October 14, 2026

• REGULATORY Japan Eyes Multi-Year Funding to Secure MCMs: Takaichi
  October 14, 2026

• BUSINESS Nitto Medic Recalls Heparinoid Lotion over Nitrosamine Impurity
  October 14, 2026

• BUSINESS Moderna Rolls Out XFG-Updated Pediatric Spikevax in Japan
  October 14, 2026

• BUSINESS Taiho to Take Over Haiyitan Marketing Authorization from Haihe
  October 14, 2026

• ORGANIZATION US VC Coalition Urges Japan to Rethink Drug Pricing, Labor Rules
  October 13, 2026

• REGULATORY Pharma Continues Reform Push at 2nd Public-Private Subgroup Meeting
  October 13, 2026

• REGULATORY AbbVie’s TrenibotE Up for Review on Oct. 26, Aquipta on Agenda Too
  October 13, 2026

• REGULATORY Japan Panel to Review Full Approval of Nipro’s Stemirac on October 15
  October 13, 2026

• REGULATORY Japan Finalizes Medical Data Sharing Blueprint, Eyes 2027 Bill
  October 13, 2026

• REGULATORY AlliedCel Takes Over Sakigake Designation for Junten Bio’s T-Cell Therapy
  October 13, 2026

• BUSINESS DNP, CMIC, NEXEL Form JV to Take iPSC-Based Drug Testing Global
  October 13, 2026

• BUSINESS Asahi Kasei Therapeutics Doses First Patient in AIC468 PIIa Trial
  October 13, 2026

• BUSINESS Kissei Group Firm Hit by Cyberattack, Personal Data at Risk
  October 13, 2026

• REGULATORY Ueno Warns Against Excessive Mounjaro Prescriptions for Foreign Tourists
  October 13, 2026

• BUSINESS Toho Drops PHC Buyout Bid, Still Exploring Growth Options
  October 13, 2026

• BUSINESS Sanwa Kagaku on Track to Resume Kumamoto Production in October
  October 13, 2026

• REGULATORY Japan Panel Again Defers Male HPV Shots amid Cost-Effectiveness Concerns
  October 9, 2026

• BUSINESS Terumo to Take US$610 Million Hit as CSL Plasma Supply Deal Ends
  October 9, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »